Cargando…
Cardiac Amyloidosis Responding to Bortezomib: Case Report and Review of Literature
We report a case of a 53-year old patient with symptoms of congestive heart failure in whom a restrictive cardiomyopathy and a kappa-chain monoclonal gammopahty were diagnosed. Treatment with eight cycles of Bortezomib, a proteasome inhibitor, resulted in a significant regression of myocardial amylo...
Autores principales: | Charaf, Edriss, Iskandar, Said B, Blevins, Ashley, Abi-Saleh, Bernard, Fahrig, Stephen |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers Ltd.
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2822146/ https://www.ncbi.nlm.nih.gov/pubmed/20676282 http://dx.doi.org/10.2174/157340309788970360 |
Ejemplares similares
-
Effectiveness of Bortezomib in Cardiac AL Amyloidosis: A Report of Two Cases
por: Nigrelli, Santi, et al.
Publicado: (2014) -
Efficacy of bortezomib, cyclophosphamide and dexamethasone in cardiac AL amyloidosis
por: Brennan, Xavier, et al.
Publicado: (2022) -
Response of Bortezomib Chemotherapy in Hepatic Amyloidosis
por: Hasan, Syed M., et al.
Publicado: (2018) -
Cardiac amyloidosis: A case report and review of literature
por: Taiwo, Adeyemi Adedamola, et al.
Publicado: (2019) -
Recurrent Syncope and Cardiac Arrest in a Patient with Systemic Light Chain Amyloidosis Treated with Bortezomib
por: Jaipaul, Navin, et al.
Publicado: (2016)